Cytokinetics, Incorporated Financial Ratios — CYTK Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-85.46	-70.48	-54.15	-19.99	-46.69	20.19	-125.16	-156.57	- -	- -	-120.54	- -	- -	- -	- -
Return on Assets (%)	-73.2	-61.95	-41.95	-13.55	-30.22	11.53	-54.97	-42.01	-48.58	-30.91	-31.32	-41.91	-57.23	-52.97	-55.55
Return on Capital (%)	- -	- -	- -	- -	- -	18.46	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	18.01	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	-371.53	-61.35	5.36	-61.9	43.71	-575.46	-182.96	-220.55	-73.66	-127.09	-154.59	-4,284.1	-1,737.22	-372.55
EBITDA Margin (%)	-1,136.88	-528.14	-109.18	-30.39	-128.47	18.26	-833.9	-278.33	-363.16	-164.99	-261.31	-336.61	-6,431.78	-2,851.13	-683.94
Operating Margin (%)	-1,169.3	-535.96	-110.59	-31.43	-130.53	17.56	-848.26	-282.26	-367.97	-168.27	-264.54	-342.75	-6,589.71	-2,902.72	-695.44
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	72.15	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,196.5	-534.07	-110.01	-31.2	-130.86	15.46	-955.94	-337.41	-452.93	-228	-305.72	-411.21	-6,988.63	-3,191.11	-891.6
Profit Margin (%)	-1,196.5	-534.07	-110.01	-31.2	-130.86	15.46	-955.94	-337.41	-452.93	-228	-305.72	-411.21	-6,988.63	-3,191.11	-891.6
Net Income to Common Margin (%)	-1,267.92	-551.36	-110.01	-31.2	-130.86	15.46	-955.94	-337.41	-452.93	-228	-305.72	-411.21	-6,988.63	-3,191.11	-891.6
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	5.63	3.14	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-80.64	-68.27	-54.15	-19.99	-46.69	20.19	-125.16	-156.57	- -	- -	-120.54	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	15	30	32	43	136	139	270	750	756	789	1,284
ST Debt	- -	- -	- -	- -	- -	2	- -	3	5	3	15	14	28	30	60
LT Debt	- -	- -	- -	- -	15	27	32	41	131	136	255	737	728	758	1,224
Total Debt/EBITDA	- -	- -	- -	- -	-0.4	1.54	-0.29	-0.49	-1.39	-1.51	-1.47	-2.36	-1.56	-1.5	-2.13
Net Debt/EBITDA	0.41	0.37	0.6	1.42	1.37	-1.9	0.84	- -	-0.95	-0.57	-0.16	-1.71	-1.04	-1.07	-1.72
Total Debt/EBIT	- -	- -	- -	- -	-0.39	1.6	-0.28	-0.49	-1.38	-1.48	-1.45	-2.31	-1.52	-1.47	-2.1
Net Debt/EBIT	0.4	0.37	0.59	1.37	1.35	-1.98	0.82	- -	-0.94	-0.56	-0.16	-1.68	-1.02	-1.05	-1.69
EBITDA to Interest Expense	-1,166.03	-19,961	- -	- -	-137.38	7.2	-6.56	-4.07	-3.57	-2.38	-6.27	-6.22	-8.4	-6.09	-5.8
EBITDA-CapEx/Interest Expense	-1,177.38	-20,023.5	- -	- -	-139.48	6.61	-6.73	-4.11	-3.66	-2.67	-7.94	-6.45	-8.42	-6.13	-6.04
EBIT to Interest Expense	-1,199.28	-20,256.5	- -	- -	-139.58	6.93	-6.67	-4.12	-3.61	-2.43	-6.35	-6.34	-8.6	-6.2	-5.89
Interest Expense	- -	- -	- -	- -	- -	3	17	22	27	39	29	51	58	87	104
Common Equity/Total Assets	91.29	90.37	65.44	69.24	59.52	55.46	37.26	12.28	-3.77	21.24	28.99	-10.63	-46.87	-9.66	-46.3
Long-Term Debt/Equity (%)	- -	- -	- -	- -	21.34	29.02	28.93	156.46	- -	120.08	104.59	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	17.59	22.04	22.44	58.71	105.05	53.96	49.64	114.65	197	116.05	195.95
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	12.7	16.09	10.78	19.21	45.36	25.51	30.32	72.58	88.29	54.09	85.92
Total Debt/Equity (%)	0.32	- -	- -	- -	21.34	31.67	28.93	166.51	-1,244.11	122.54	110.69	-695.37	-195.63	-582.6	-194.69
Total Debt/Capital (%)	0.31	- -	- -	- -	17.59	24.05	22.44	62.48	108.74	55.06	52.54	116.8	204.57	120.72	205.6
Total Debt/Total Assets (%)	0.29	- -	- -	- -	12.7	17.56	10.78	20.45	46.95	26.03	32.08	73.94	91.68	56.27	90.15
Net Debt to Equity	-38.77	-21.27	-37.03	-21.96	-73.53	-39.2	-85.06	0.61	-848.72	46.5	12.37	-505.09	-130.57	-415.34	-156.85
Net Debt/Capital (%)	-63.33	-27.02	-58.8	-28.14	-277.84	-64.48	-569.24	0.58	104.65	31.14	7.52	94.48	196.72	100.68	206.06
EBITDA	-45	-40	-33	-14	-37	19	-111	-88	-98	-92	-184	-318	-484	-527	-602
EBITDA-CapEx	-46	-40	-34	-15	-37	18	-114	-89	-100	-103	-233	-330	-486	-531	-627
Operating Income (Loss)	-47	-41	-34	-15	-37	19	-113	-89	-99	-94	-186	-324	-496	-536	-612

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	10.68	10.42	2.91	3.49	3.52	4.7	8.29	8.95	8.65	14.87	6.56	9.25	5.99	5.99	4.36
Current Ratio	11.14	10.76	2.97	5.5	3.57	4.77	8.45	9.36	8.98	15.2	7.45	9.4	6.12	6.17	4.53
Quick Ratio	10.68	10.42	2.91	5.44	3.52	4.7	8.32	9.26	8.85	15.02	7.28	9.25	6	6.08	4.45
CFO/Avg Current Liab	-7.65	-5.72	-0.46	-1.77	0.18	1.14	-3.1	-3.7	-3.77	0.31	-2.77	-3.83	-4.42	-2.8	-2.67
Common Equity/Total Assets	91.29	90.37	65.44	69.24	59.52	55.46	37.26	12.28	-3.77	21.24	28.99	-10.63	-46.87	-9.66	-46.3
Long-Term Debt/Equity (%)	- -	- -	- -	- -	21.34	29.02	28.93	156.46	- -	120.08	104.59	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	17.59	22.04	22.44	58.71	105.05	53.96	49.64	114.65	197	116.05	195.95
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	12.7	16.09	10.78	19.21	45.36	25.51	30.32	72.58	88.29	54.09	85.92
Total Debt/Equity (%)	0.32	- -	- -	- -	21.34	31.67	28.93	166.51	-1,244.11	122.54	110.69	-695.37	-195.63	-582.6	-194.69
Total Debt/Capital (%)	0.31	- -	- -	- -	17.59	24.05	22.44	62.48	108.74	55.06	52.54	116.8	204.57	120.72	205.6
Total Debt/Total Assets (%)	0.29	- -	- -	- -	12.7	17.56	10.78	20.45	46.95	26.03	32.08	73.94	91.68	56.27	90.15
CFO/Total Liabilities	-992.27	-447.87	-26.85	-109.63	10.47	48.8	-55.01	-54.64	-30.23	2.13	-23.85	-26.68	-34.22	-25.76	-24.47
CFO/CapEx	-102.92	-267.5	-14.24	-40.62	8.69	23.17	-35.37	-113.85	-34.71	0.81	-2.92	-26.42	-292.61	-101.35	-20.56
Altman's Z-Score	-3.24	-1.1	-4.18	0.26	-1.15	1.52	-1.88	-3.99	-3.1	0.02	1.89	0.01	-0.59	-0.98	-1.93

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	133.33	839.89	6,810.67	2.01	1.23	5,911.5	23.54	18.85	7.27	11.65	2.5	3.64	10.53	2.06	5.12
Days Sales Outstanding	2.74	0.43	0.05	181.38	297.13	0.06	15.51	19.37	50.22	31.33	145.73	100.26	34.66	177.16	71.34
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	21.22	16.87	17.53	25.78	18.5	19.03	19.77	14.45	11.96	10.98	10.31	14.01	16.21	19.48
Accounts Payable Turnover Days	- -	17.2	21.63	20.83	14.16	19.73	19.18	18.46	25.27	30.51	33.25	35.39	26.05	22.52	18.73
Cash Conversion Cycle	-8.68	-16.77	-21.58	160.55	282.97	-19.66	-3.67	0.91	24.96	0.81	112.48	64.87	8.61	154.64	52.6
Inventory to Cash Days	2.74	0.43	0.05	181.38	297.13	0.06	15.51	19.37	50.22	31.33	145.73	100.26	34.66	177.16	71.34
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	72	94	199	310	414	494	440	346	628	1,476	3,865	4,345	8,486	5,561	7,812
- Cash & Cash Equivalents	19	15	20	20	65	67	125	42	36	83	113	66	113	95	123
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	15	30	32	43	136	139	270	750	756	789	1,284
Enterprise Value	23	20	122	226	317	367	203	190	539	1,151	3,663	4,313	8,627	5,273	8,214
Total Capital	48	70	54	92	83	124	142	69	125	252	514	642	369	653	625
Total Debt/Capital (%)	0.31	- -	- -	- -	17.59	24.05	22.44	62.48	108.74	55.06	52.54	116.8	204.57	120.72	205.6
Total Debt / EV	0.01	- -	- -	- -	0.05	0.08	0.16	0.23	0.25	0.12	0.07	0.17	0.09	0.15	0.16
EV/Sales	5.76	2.65	3.97	4.82	11.07	3.45	15.16	6.04	20.05	20.61	52.02	45.6	1,145.64	285.44	93.3
EV/EBITDA	- -	- -	- -	- -	- -	18.92	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	19.67	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	61.58	9.26	- -	- -	- -	24.16	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	55.53	8.9	- -	- -	- -	19.61	- -	- -	- -	- -	- -
Diluted Market Cap	68	72	177	286	406	517	403	344	611	1,341	3,504	4,116	8,059	5,267	7,631
Diluted Enterprise Value	49	57	157	266	356	480	309	345	711	1,397	3,662	4,800	8,702	5,961	8,793
EV per Share	1.85	0.84	3.97	5.86	8.01	9.04	3.76	3.48	9.11	16.2	43.2	45.48	84.88	44.61	66.81
TTM Sales	4	8	31	47	29	106	13	32	27	56	70	95	8	18	88
TTM EBITDA	-45	-40	-33	-14	-37	19	-111	-88	-98	-92	-184	-318	-484	-527	-602
TTM Operating Income	-47	-41	-34	-15	-37	19	-113	-89	-99	-94	-186	-324	-496	-536	-612
TTM Cash Flow to Firm	-46	-33	-8	-45	5	40	-85	-80	-64	48	-113	-248	-357	-309	-406
TTM Free Cash Flow to Firm	-45	-33	-7	-44	6	41	-82	-79	-61	59	-64	-237	-355	-305	-381

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-1.51	-2.15	-24.71	-6.54	74.56	13.4	-4.07	-3.43	-6.92	67.06	-37.42	-14.28	-19.52	-13.44	-15.73
EV/EBIT	- -	- -	- -	- -	- -	19.67	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	23	20	122	226	317	367	203	190	539	1,151	3,663	4,313	8,627	5,273	8,214
Low Price	5.34	3.42	3.96	3.05	5.5	6	7	5.9	5.75	8	17.72	29.26	25.98	45.66	29.31
EV/Sales	5.76	2.65	3.97	4.82	11.07	3.45	15.16	6.04	20.05	20.61	52.02	45.6	1,145.64	285.44	93.3
EV/EBITDA	- -	- -	- -	- -	- -	18.92	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	29.5	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-1.85	-2.25	-6.37	-14.32	-7.94	22.23	-4.89	-4.13	-4.73	-9.29	-10.11	-9.65	-6.75	-11.62	-7.06
Price/Earnings High	-3.03	-3.36	-11.55	-32.33	-13.64	31.51	-6.65	-5.25	-7.07	-15.28	-17.1	-12.89	-16.06	-20.94	-10.86
Price/Earnings Low	-1.24	-1.49	-3.2	-7.44	-5.69	14.57	-2.71	-3.02	-2.72	-4.06	-6.33	-6.76	-4.77	-8.67	-4.48
Price/Book Value	1.49	1.34	3.66	3.36	6.04	5.23	4	13.33	-57.4	13.02	15.85	-40.27	-21.97	-41.08	-11.84
Price/Book Value Average	2.07	1.76	4.44	2.47	4.43	3.94	6.22	17.01	-54.03	11.48	9.85	-36.72	-9.68	-53.4	-8.6
Price/Book Value High	3.37	2.62	8.05	5.57	7.61	5.59	8.45	21.65	-80.83	18.88	16.66	-49.04	-23.04	-96.27	-13.23
Price/Book Value Low	1.38	1.16	2.23	1.28	3.17	2.58	3.44	12.45	-31.11	5.01	6.16	-25.72	-6.84	-39.87	-5.46
Price/Tangible Book Value	1.49	1.34	3.66	3.36	6.04	5.23	4	13.33	-57.4	13.02	15.85	-40.27	-21.97	-41.08	-11.84
Price/Tangible Book Value Average	2.07	1.76	4.44	2.47	4.43	3.94	6.22	17.01	-54.03	11.48	9.85	-36.72	-9.68	-53.4	-8.6
Price/Tangible Book Value High	3.37	2.62	8.05	5.57	7.61	5.59	8.45	21.65	-80.83	18.88	16.66	-49.04	-23.04	-96.27	-13.23
Price/Tangible Book Value Low	1.38	1.16	2.23	1.28	3.17	2.58	3.44	12.45	-31.11	5.01	6.16	-25.72	-6.84	-39.87	-5.46
Price/Sales	16.99	9.49	5.78	6.09	14.17	4.56	30.12	10.92	22.74	24.02	49.76	43.51	1,070.22	285.13	86.68
Price/Sales Average	23.51	12.43	7.01	4.47	10.39	3.44	46.76	13.93	21.4	21.19	30.91	39.67	471.86	370.7	62.93
Price/Sales High	38.41	18.54	12.71	10.09	17.85	4.87	63.57	17.72	32.01	34.83	52.29	52.99	1,122.65	668.27	96.83
Price/Sales Low	15.75	8.19	3.52	2.32	7.45	2.25	25.87	10.19	12.32	9.25	19.34	27.79	333.03	276.77	39.98
Price/Cash Flow	-1.49	-2.14	-22.97	-6.38	83.14	13.12	-3.96	-3.4	-6.72	149.93	-24.59	-13.74	-19.45	-13.31	-14.96
Price/Cash Flow Average	-2.06	-2.81	-27.82	-4.68	60.98	9.89	-6.14	-4.33	-6.33	132.3	-15.28	-12.53	-8.58	-17.3	-10.86
Price/Cash Flow High	-3.37	-4.19	-50.46	-10.56	104.77	14.02	-8.35	-5.52	-9.46	217.46	-25.84	-16.73	-20.4	-31.18	-16.72
Price/Cash Flow Low	-1.38	-1.85	-13.99	-2.43	43.72	6.48	-3.4	-3.17	-3.64	57.72	-9.56	-8.78	-6.05	-12.92	-6.9
Price/Free Cash Flow Average	-2.08	-2.82	-29.92	-4.79	54.68	10.1	-6.32	-4.37	-6.51	59.17	-23.25	-13.02	-8.6	-17.47	-11.42
Price/Free Cash Flow High	-3.4	-4.21	-54.28	-10.83	93.95	14.32	-8.59	-5.57	-9.74	97.26	-39.33	-17.39	-20.47	-31.5	-17.57
Price/Free Cash Flow Low	-1.4	-1.86	-15.05	-2.49	39.21	6.62	-3.5	-3.2	-3.75	25.82	-14.55	-9.12	-6.07	-13.04	-7.26
EV/Sales Average	20.21	14.33	7.22	4.41	8.84	3.15	44.09	14.03	25.7	24.33	36.33	49.12	582.22	428.88	77.61
EV/Sales High	35.97	22.34	13.64	10.49	16.44	4.61	62.44	17.85	36.61	39.34	59.91	63.18	1,267.49	743.01	112.32
EV/Sales Low	12	8.77	3.31	2.08	5.84	1.94	21.27	10.28	16.37	11.18	23.57	36.58	436.03	329.72	54.13
EV/EBITDA Average	-1.78	-2.71	-6.62	-14.5	-6.88	17.25	-5.29	-5.04	-7.08	-14.74	-13.9	-14.59	-9.05	-15.04	-11.35
EV/EBITDA High	-3.16	-4.23	-12.49	-34.52	-12.8	25.25	-7.49	-6.41	-10.08	-23.84	-22.93	-18.77	-19.71	-26.06	-16.42
EV/EBITDA Low	-1.06	-1.66	-3.03	-6.85	-4.54	10.65	-2.55	-3.69	-4.51	-6.78	-9.02	-10.87	-6.78	-11.56	-7.91
EV/EBIT Average	-1.73	-2.67	-6.53	-14.02	-6.77	17.94	-5.2	-4.97	-6.98	-14.46	-13.73	-14.33	-8.84	-14.78	-11.16
EV/EBIT High	-3.08	-4.17	-12.33	-33.37	-12.6	26.25	-7.36	-6.32	-9.95	-23.38	-22.65	-18.43	-19.23	-25.6	-16.15
EV/EBIT Low	-1.03	-1.64	-2.99	-6.62	-4.47	11.07	-2.51	-3.64	-4.45	-6.64	-8.91	-10.67	-6.62	-11.36	-7.78
Last Price	5.76	3.96	6.5	8.01	10.46	12.15	8.15	6.32	10.61	20.78	45.58	45.82	83.49	47.04	63.54
High Price	13.02	7.74	14.28	13.26	13.18	12.98	17.2	10.26	14.94	30.14	47.9	55.8	87.58	110.25	70.98
Enterprise Value Average	81	108	221	207	253	335	589	442	691	1,358	2,558	4,646	4,384	7,923	6,833
Enterprise Value High	144	169	418	492	471	491	835	562	984	2,196	4,219	5,976	9,544	13,726	9,888
Enterprise Value Low	48	66	101	98	167	207	284	324	440	624	1,660	3,460	3,283	6,091	4,765

Shares Outstanding	12	24	31	39	40	41	54	55	59	71	85	95	102	118	123
Diluted Weighted Avg Shares	12	18	27	36	39	43	49	54	58	65	77	90	97	112	120
Basic Weighted Avg Shares	12	18	27	36	39	40	49	54	58	65	77	90	97	112	120
Revenue per Share	0.34	0.42	1.12	1.31	0.74	2.66	0.27	0.58	0.47	0.87	0.92	1.05	0.08	0.16	0.73
EBITDA per Share	-3.85	-2.2	-1.23	-0.4	-0.95	0.49	-2.26	-1.61	-1.69	-1.43	-2.39	-3.54	-5.02	-4.7	-5.01
Operating Income per Share	-3.96	-2.24	-1.24	-0.41	-0.96	0.47	-2.3	-1.63	-1.72	-1.46	-2.42	-3.61	-5.14	-4.79	-5.1
Basic EPS, GAAP	-4.3	-2.3	-1.24	-0.41	-0.97	0.41	-2.59	-1.95	-2.11	-1.97	-2.8	-4.33	-5.45	-5.26	-6.54
Basic EPS from Cont Ops	-4.06	-2.23	-1.24	-0.41	-0.97	0.41	-2.59	-1.95	-2.11	-1.97	-2.8	-4.33	-5.45	-5.26	-6.54
Diluted EPS, GAAP	-4.3	-2.3	-1.24	-0.41	-0.97	0.39	-2.59	-1.95	-2.11	-1.97	-2.8	-4.33	-5.45	-5.26	-6.54
Diluted EPS from Cont Ops	-4.06	-2.23	-1.24	-0.41	-0.97	0.39	-2.59	-1.95	-2.11	-1.97	-2.8	-4.33	-5.45	-5.26	-6.54
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3.86	-1.85	-0.28	-1.26	0.13	0.93	-2.06	-1.86	-1.58	0.14	-1.85	-3.33	-4.29	-3.54	-4.25
Free Cash Flow per Basic Share	-3.9	-1.85	-0.3	-1.29	0.11	0.89	-2.12	-1.88	-1.62	-0.03	-2.49	-3.46	-4.31	-3.57	-4.45
Cash & Equivalents per Share	3.93	3.12	2.53	2.15	2.82	3.84	4.98	3.63	3.8	6.53	5.56	8.25	6.05	9.1	7.18
Book Value per Share	3.86	2.95	1.77	2.38	1.73	2.32	2.04	0.47	-0.18	1.6	2.88	-1.14	-3.8	-1.15	-5.37
Tangible Book Value per Share	3.86	2.95	1.77	2.38	1.73	2.32	2.04	0.47	-0.18	1.6	2.88	-1.14	-3.8	-1.15	-5.37

Cytokinetics, Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)